Sectors

Sovereign immunity: a venue-dependent protection

A recent University of Texas dispute perfectly illustrates the differing role sovereign immunity takes in proceedings at the Patent Trial and Appeal Board and district court, say Simon Roberts, Nitya Anand and Eric Wang of Hogan Lovells.

• EPO’s new examination guidelines: what you need to know 06-04-2021
• The uncertain future of antibody claims 01-04-2021
• Got a patent, now where to validate? 22-03-2021
• Patent filing strategies for pharma startups 16-03-2021
• Texas Uni’s sovereign immunity fail went as expected 04-03-2021

More features